• Cinoxacin Workflows for Gram-Negative UTI Research

  2026-09-03

  Cinoxacin provides a historically defined quinolone antibiotic comparator for susceptibility testing, time-kill experiments, and resistance selection in urinary Gram-negative isolates. Its narrow activity profile and practical assay benchmarks make it especially useful for controlled urinary tract infection research rather than broad-spectrum screening.

• Acridine Orange hydrochloride: Practical Staining Guide

  2026-09-03

  Acridine Orange hydrochloride provides cell-permeable, differential fluorescence for nucleic acid staining, supporting cell cycle analysis, apoptosis detection, and flow-based DNA/RNA assessment. This guide explains preparation, controls, readout planning, and limitations; it should not be treated as a universal substitute for orthogonal apoptosis or nucleic acid assays.

• AO/PI Staining Solution for Viability Workflows

  2026-09-02

  AO/PI Staining Solution delivers a two-color readout for separating nucleated live and membrane-compromised cells, making it useful when trypan blue is vulnerable to debris or red blood cell interference. This article translates that principle into practical workflows for podocyte, PBMC, cytotoxicity, and fluorescence-based cell counting applications.

• LY294002 Workflows for PI3K Pathway Studies

  2026-09-02

  LY294002 provides a reversible way to interrogate class I PI3K signaling across pathway, apoptosis, autophagy, and tumor-cell assays. This practical guide connects dose selection and washout experiments with the FGFR–TGFβ–PI3K/AKT regulatory model reported in HER2-positive breast cancer research.

• Chemotherapy Enhances Neoantigen-Directed T Cell Therapy

  2026-09-01

  Sagie et al. identify T104, a KRAS.G12V-specific T cell receptor, and show that lymphodepleting chemotherapy can improve neoantigen presentation rather than serving only as preparative treatment. By increasing immunoproteasome activity, HLA-I surface expression, and the abundance of selected presented peptides, chemotherapy enhanced tumor-cell recognition by TCR-T cells, TILs, and T cell engagers across preclinical models.

• Plerixafor (AMD3100): CXCR4 Research Guide

  2026-09-01

  Plerixafor (AMD3100) is a small-molecule CXCR4 antagonist that disrupts CXCL12/SDF-1 signaling, hematopoietic stem cell retention, and chemotaxis. Its strongest research uses are hematopoietic stem cell mobilization, cancer metastasis inhibition studies, and immune-cell trafficking assays, while disease-treatment conclusions require model-specific validation.

• Salmonella Haem, SirM, and Phagocytosis Resistance

  2026-08-31

  The reference study identifies SirM as a Salmonella methyltransferase that increases HemL activity, elevates bacterial haem production, and suppresses macrophage phagocytosis through TLR4-dependent inhibition of Cdc42 activation. Its Tn-seq-to-animal-model workflow shows that haem biosynthesis can contribute to virulence through immune modulation, not only through iron acquisition.

• Merbromin as a Mixed-Type SARS-CoV-2 3CLpro Inhibitor

  2026-08-31

  A high-throughput biochemical study identified merbromin as a selective inhibitor of SARS-CoV-2 3CLpro and characterized its mixed-type inhibition through kinetics, binding assays, and molecular docking. The work is important because it links screening activity with a preliminary selectivity profile while also defining the limitations of extrapolating enzyme inhibition to antiviral efficacy.

• SGI-1027 and Everolimus in Renal Cancer

  2026-08-30

  A 2024 Advanced Science study identifies SGI-1027 as a methuosis inducer and shows that it cooperates with everolimus to suppress renal cancer through lysosomal membrane permeability, apoptosis, and GSDME-dependent pyroptosis. The findings suggest a way to diversify cell-death responses and address limitations associated with everolimus resistance, while highlighting the need for validation in broader and clinically relevant models.

• Anlotinib Hydrochloride: From Mechanism to Translation

  2026-08-29

  An evidence-led perspective on how Anlotinib hydrochloride connects VEGFR2, PDGFRβ, and FGFR1 biology with reproducible angiogenesis assays, competitive positioning, and translational decision-making in cancer research.

• Caspofungin: Reading Glucan-Targeted Assays

  2026-08-28

  Caspofungin is a lipopeptide antifungal drug whose value extends beyond growth inhibition. This article presents a mechanistic framework for connecting glucan synthase inhibition, resistance biology, and clinically relevant assay design in Candida research.

• GW 4869: Exosome and Osteogenesis Workflows

  2026-08-28

  GW 4869 helps distinguish vesicle-mediated signaling from soluble-factor effects in stem-cell, bone-regeneration, inflammatory, and extracellular-vesicle studies. This practical guide connects neutral sphingomyelinase inhibition with lithium-engineered BMSC exosomes, assay controls, dosing logic, and troubleshooting.

• Lenalidomide (CC-5013): Rewiring Myeloma Immunity

  2026-08-27

  Lenalidomide (CC-5013) is more than a conventional antineoplastic agent: it is an immune system activation agent, angiogenesis inhibitor, and TNF-alpha secretion inhibitor with a compelling role in multiple myeloma research. New findings position DOT1L inhibition as a mechanistically grounded strategy for amplifying lenalidomide-associated innate immune signaling while suppressing IRF4-MYC biology.

• Proteinase K for DNA Prep: Workflow & Troubleshooting

  2026-08-27

  Proteinase K converts difficult lysis and cleanup steps into a controlled strategy for genomic DNA recovery, nuclease destruction, and protein hydrolysis in molecular biology. This practical guide shows how to tune digestion, protect DNA integrity, and use the enzyme as a specificity control in protease assays.

• LNP Surface Charge and V-ATPase Synergy

  2026-08-26

  This study proposes that lipid nanoparticle (LNP) tropism depends on a two-sided interaction between particle surface charge and the V-ATPase activity of target cells. Its in vitro and in vivo experiments connect cellular endo/lysosomal state with charge-dependent delivery, offering a mechanistic framework for interpreting organ selectivity and delivery efficiency.

555 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page